Drawing for LAND VIEW INC.

USPTO serial 87190540

LAND VIEW INC.

Reviewed by CopyMark Law Group

Reg. 5217106Status 702Renewal
Filing date
Status date
Registration date
Jun 6, 2017
Examiner
PERKINS, ELLEN J
Law office
TMO LAW OFFICE 110

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with LAND VIEW INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*

Plus Government fees of $3,250

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

APRIL PEARSON

APRIL PEARSON AVRILEX PLLC20433 W Calle EncorvadaBuckeye, AZ 85396UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Fertilizers for agricultural useACTIVEFeb 26, 2007
005Pesticides for agricultural useACTIVEFeb 26, 2007
035Retail store services featuring agricultural chemicals, seeds and fertilizersACTIVEFeb 26, 2007
039Distribution services, namely, delivery of agricultural chemicals, seeds and fertilizersACTIVEFeb 26, 2007
044Agronomic consulting servicesACTIVEFeb 26, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 10, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 10, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 10, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 24, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Jun 6, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 6, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 27, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 11, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 11, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 4, 2017CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Jan 3, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 3, 2017ALIEASSIGNED TO LIE—
Jan 3, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 3, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 3, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 2, 2017DOCKASSIGNED TO EXAMINER—
Oct 7, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 6, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 5, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance